JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, R. T.
Right arrow Articles by Bresnahan, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, R. T.
Right arrow Articles by Bresnahan, W. A.
Journal of Virology, November 2006, p. 10763-10771, Vol. 80, No. 21
0022-538X/06/$08.00+0     doi:10.1128/JVI.01195-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Human Cytomegalovirus IE86 Attenuates Virus- and Tumor Necrosis Factor Alpha-Induced NF{kappa}B-Dependent Gene Expression

R. Travis Taylor{dagger} and Wade A. Bresnahan*

Department of Microbiology, University of Minnesota, 1060 Mayo Building, MMC196, Minneapolis, Minnesota 55455

Received 6 June 2006/ Accepted 9 August 2006

Human cytomegalovirus (HCMV) infection regulates a number of genes involved in the host antiviral response. We have previously reported that HCMV attenuates the expression of beta interferon (IFN-ß) and a number of proinflammatory chemokines, and this attenuation is mediated by the HCMV immediate-early protein IE86. The present study seeks to identify the mechanism by which IE86 blocks IFN-ß expression. We demonstrate that the induction of IFN-ß during HCMV infection requires the activation of both the IRF-3 and the NF{kappa}B pathways. Therefore, IE86 may target either pathway to block IFN-ß expression. Our results show that IE86 does not block IRF-3 phosphorylation, dimerization, nuclear translocation, or target gene expression. However, using gel shift analysis, we demonstrate that IE86 efficiently inhibits virus-induced binding of NF{kappa}B to the IFN-ß promoter, resulting in attenuation of IFN-ß and NF{kappa}B-dependent gene expression. Furthermore, IE86 expression inhibits tumor necrosis factor alpha-induced NF{kappa}B DNA binding and target gene expression. Together, these results identify IE86 as a NF{kappa}B antagonist, which results in the suppression of NF{kappa}B-dependent cytokine and chemokine gene expression.


* Corresponding author. Mailing address: University of Minnesota, Department of Microbiology, 1060 Mayo Building, MMC196, 420 Delaware Street SE, Minneapolis, MN 55455. Phone: (612) 626-5876. Fax: (612) 626-0623. E-mail: bresn013{at}umn.edu.

{dagger} Present address: UT Southwestern Medical Center, Department of Microbiology, 6000 Harry Hines Blvd, Dallas, TX 75390.


Journal of Virology, November 2006, p. 10763-10771, Vol. 80, No. 21
0022-538X/06/$08.00+0     doi:10.1128/JVI.01195-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.